Patents by Inventor Walter Robert Bishop

Walter Robert Bishop has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fully human anti-VEGF antibodies and methods of using
    Patent number: 8216571
    Abstract: Disclosed herein are fully human antibodies and antigen-binding fragments thereof that specifically bind human VEGF and inhibit VEGF binding to VEGF-R1 and VEGF-R2, and therefore inhibit VEGF signaling. The antibodies and antigen-binding fragments disclosed herein may be used, for example, to treat angiogenesis and conditions associated with angiogenesis both in vivo and in vitro.
    Type: Grant
    Filed: October 20, 2008
    Date of Patent: July 10, 2012
    Assignee: Schering Corporation
    Inventors: Sumant Ramachandra, Walter Robert Bishop, Linda Masat, Chao Bai Huang, Toshihiko Takeuchi, Seema Kantak, Chin-Yi Huang
  • Anti-IGFR1 antibody therapeutic combinations
    Patent number: 8017735
    Abstract: The present invention provides combinations including a binding composition, such as an anti-IGFR1 antibody, in association with a chemotherapeutic agent. Methods for using the combinations to treat medical conditions, such as cancer, are also provided.
    Type: Grant
    Filed: November 19, 2004
    Date of Patent: September 13, 2011
    Assignee: Schering Corporation
    Inventors: Yan Wang, Jonathan A. Pachter, Walter Robert Bishop
  • METHODS FOR TREATING OR PREVENTING COLORECTAL CANCER
    Publication number: 20110104256
    Abstract: The present invention provides, for example, methods for treating or preventing colorectal cancer with an anti-IGF1R antibody in association with sunitinib or a combination of leucovorin and 5-fluorouracil.
    Type: Application
    Filed: March 23, 2009
    Publication date: May 5, 2011
    Inventors: Yaolin Wang, Yan Wang, Ming Liu, Walter Robert Bishop, Cynthia Seidel-Dugan
  • FULLY HUMAN ANTI-VEGF ANTIBODIES AND METHODS OF USING
    Publication number: 20110097340
    Abstract: Disclosed herein are fully human antibodies and antigen-binding fragments thereof that specifically bind human VEGF and inhibit VEGF binding to VEGF-R1 and VEGF-R2, and therefore inhibit VEGF signaling. The antibodies and antigen-binding fragments disclosed herein may be used, for example, to treat angiogenesis and conditions associated with angiogenesis both in vivo and in vitro.
    Type: Application
    Filed: October 20, 2008
    Publication date: April 28, 2011
    Inventors: Sumant Ramachandra, Walter Robert Bishop, Linda Masat, Chao Bai Huang, Toshihiko Takeuchi, Seema Kantak, Chin-Yi Huang's
  • FULLY HUMAN ANTI-VEGF ANTIBODIES AND METHODS OF USING
    Publication number: 20110076279
    Abstract: Vascular endothelial growth factor (VEGF) overexpression is associated with a variety of conditions involving aberrant angiogenesis. Disclosed herein are fully human antibodies that specifically bind human VEGF and inhibit VEGF binding to VEGF-R1 and VEGF-R2, and therefore inhibit VEGF signaling Based on their ability to inhibit VEGF signaling, the antibodies disclosed herein may be used to treat angiogenesis and conditions associated with angiogenesis both in vivo and in vitro.
    Type: Application
    Filed: October 22, 2007
    Publication date: March 31, 2011
    Applicants: SCHERING CORPORATION, XOMA TECHNOLOGY LTD.
    Inventors: Sumant Ramachandra, Walter Robert Bishop, Linda Masat, Chao Bai Huang
  • METHODS OF TREATING CELL PROLIFERATIVE DISORDERS USING A COMPRESSED TEMOZOLOMIDE DOSING SCHEDULE
    Publication number: 20100240723
    Abstract: There are disclosed methods and kits for treating cancer in a patient in need of such treating comprising administering temozolomide according to improved dosing schedules.
    Type: Application
    Filed: March 31, 2010
    Publication date: September 23, 2010
    Inventors: WALTER ROBERT BISHOP, PAUL KIRSCHMEIER, MING LIU
  • PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING TEMOZOLOMIDE AND MULTI-TARGETED KINASE INHIBITORS
    Publication number: 20100087499
    Abstract: The present invention provides formulations, kits and methods useful for treating cell proliferative disorder. In particular, the formulations, kits and methods include temozolomide (TMZ) in combination with a multi-targeted kinase inhibitor.
    Type: Application
    Filed: January 28, 2008
    Publication date: April 8, 2010
    Applicant: SCHERING CORPORATION
    Inventors: Yaolin Wang, Ming Liu, Walter Robert Bishop
  • METHODS OF TREATING CELL PROLIFERATIVE DISORDERS USING A COMPRESSED TEMOZOLOMIDE DOSING SCHEDULE
    Publication number: 20090247599
    Abstract: There are disclosed methods and kits for treating cancer in a patient in need of such treating comprising administering temozolomide according to improved dosing schedules.
    Type: Application
    Filed: April 8, 2009
    Publication date: October 1, 2009
    Inventors: Walter Robert Bishop, Paul Kirschmeier, Ming Liu
  • Methods of treating cell proliferative disorders using a compressed temozolomide dosing schedule
    Publication number: 20070111979
    Abstract: There are disclosed methods and kits for treating cancer in a patient in need of such treating comprising administering temozolomide according to improved dosing schedules.
    Type: Application
    Filed: November 7, 2006
    Publication date: May 17, 2007
    Inventors: Walter Robert Bishop, Paul Kirschmeier, Ming Liu